Vortioxetine Hydrobromide 960203-27-4

The function of Vortioxetine hydrobromide is as follows:

1.     Antidepressant: Vortioxetine hydrobromide is a novel antidepressant with a multimodal mechanism of action that comprehensively improves depressive symptoms, including emotional, physical, and cognitive aspects. It has been shown to be effective in treating major depressive disorder (MDD), depression with severe anxiety, generalized anxiety disorder (GAD), and for patients who have failed to respond to treatment with selective serotonin reuptake inhibitors (SSRIs) or serotonin-norepinephrine reuptake inhibitors (SNRIs).

2.     Reducing the Risk of Disease Recurrence: In addition to directly improving depressive symptoms, vortioxetine hydrobromide can also reduce the risk of disease recurrence, helping patients stabilize their mood and minimize disease fluctuations.

3.     Improving Daily Social Functioning and Cognitive Function: While improving depressive symptoms, vortioxetine hydrobromide can also enhance patients' daily social functioning and cognitive function, enabling them to better integrate into society and improve their quality of life.

4.     Multiple Mechanisms of Action: Vortioxetine hydrobromide modulates the activity of multiple serotonin receptors in the brain, which play crucial roles in regulating mood, cognitive function, and overall mental health. By balancing neurotransmitters, vortioxetine hydrobromide helps restore mood and improve depressive symptoms and cognitive function.

5.     High Safety: Compared to traditional antidepressants, vortioxetine hydrobromide has a lower incidence of adverse events and a higher safety profile.

*Products under the patent are only for R&D use